TH

Teru Hideshima

DI Dana-Farber Cancer Institute: 10 patents #66 of 1,343Top 5%
AP Acetylon Pharmaceuticals: 3 patents #12 of 29Top 45%
Harvard University: 3 patents #733 of 3,600Top 25%
The General Hospital: 3 patents #583 of 3,021Top 20%
BA Biotest Ag: 1 patents #35 of 62Top 60%
IM Immunogen: 1 patents #78 of 119Top 70%
📍 Brookline, MA: #294 of 3,196 inventorsTop 10%
🗺 Massachusetts: #8,835 of 88,656 inventorsTop 10%
Overall (All Time): #339,417 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12053468 Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof Steven Norman Quayle, Simon Stewart Jones, Kenneth C. Anderson 2024-08-06
11497746 Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof Steven Norman Quayle, Simon Stewart Jones, Kenneth C. Anderson 2022-11-15
RE49240 Inhibitors of histone deacetylase Ralph Mazitschek, Kenneth C. Anderson, Stephen J. Haggarty, Balaram Ghosh 2022-10-11
11447467 Compounds for the degradation of STK4 and treatment of hematologic malignancies Sara Jean Buhrlage, Kenneth C. Anderson, Nathanael S. Gray, Xiaoxi Liu 2022-09-20
11337975 Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof Steven Norman Quayle, Simon Stewart Jones, Kenneth C. Anderson 2022-05-24
10302644 Compositions and methods for treating multiple myeloma Kenneth C. Anderson, Francesca Cottini 2019-05-28
10172905 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2019-01-08
9988343 Inhibitors of histone deacetylase Ralph Mazitschek, Kenneth C. Anderson, Stephen J. Haggarty, Balaram Ghosh 2018-06-05
9969679 Anti-proliferative compounds and uses thereof Kenneth C. Anderson, Ralph Mazitschek, Gullu Gorgun 2018-05-15
9572854 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2017-02-21
9446146 Methods and agents for improving targeting of CD138 expressing tumor cells Benjamin Daelken, Christoph Uherek, Kenneth C. Anderson, Christoph Bruecher, Frank Osterroth +2 more 2016-09-20
8999289 Treatment of protein degradation disorders Kenneth C. Anderson, James E. Bradner, Edward Franklin Greenberg, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2015-04-07
8685954 Methods and compositions for treating cancer using proteasome inhibitors Kenneth C. Anderson, Constantine S. Mitsiades, Nicholas Mitsiades 2014-04-01
8026230 Methods and compositions for treating cancer using proteasome inhibitors Kenneth C. Anderson, Constantine S. Mitsiades, Nicholas Mitsiades 2011-09-27